235 related articles for article (PubMed ID: 35871390)
21. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
[TBL] [Abstract][Full Text] [Related]
22. LASSO-based machine learning models for the prediction of central lymph node metastasis in clinically negative patients with papillary thyroid carcinoma.
Feng JW; Ye J; Qi GF; Hong LZ; Wang F; Liu SY; Jiang Y
Front Endocrinol (Lausanne); 2022; 13():1030045. PubMed ID: 36506061
[TBL] [Abstract][Full Text] [Related]
23. Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
Hopkins AM; Wagner J; Kichenadasse G; Modi N; Rowland A; Sorich MJ
Int J Cancer; 2020 Dec; 147(11):3085-3089. PubMed ID: 32492185
[TBL] [Abstract][Full Text] [Related]
24. Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced-stage EGFR-mutated non-small-cell lung cancer.
Kim T; Lee SJ; Jang TW
Thorac Cancer; 2022 Dec; 13(23):3353-3361. PubMed ID: 36278315
[TBL] [Abstract][Full Text] [Related]
25. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Rittmeyer A; Barlesi F; Waterkamp D; Park K; Ciardiello F; von Pawel J; Gadgeel SM; Hida T; Kowalski DM; Dols MC; Cortinovis DL; Leach J; Polikoff J; Barrios C; Kabbinavar F; Frontera OA; De Marinis F; Turna H; Lee JS; Ballinger M; Kowanetz M; He P; Chen DS; Sandler A; Gandara DR;
Lancet; 2017 Jan; 389(10066):255-265. PubMed ID: 27979383
[TBL] [Abstract][Full Text] [Related]
26. Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Study.
Woodman RJ; Bryant K; Sorich MJ; Pilotto A; Mangoni AA
J Med Internet Res; 2021 Jun; 23(6):e26139. PubMed ID: 34152274
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.
Feng X; Hong T; Liu W; Xu C; Li W; Yang B; Song Y; Li T; Li W; Zhou H; Yin C
Front Endocrinol (Lausanne); 2022; 13():1054358. PubMed ID: 36465636
[TBL] [Abstract][Full Text] [Related]
28. Biological signatures and prediction of an immunosuppressive status-persistent critical illness-among orthopedic trauma patients using machine learning techniques.
Lei M; Han Z; Wang S; Guo C; Zhang X; Song Y; Lin F; Huang T
Front Immunol; 2022; 13():979877. PubMed ID: 36325351
[TBL] [Abstract][Full Text] [Related]
29. Machine learning models in the prediction of 1-year mortality in patients with advanced hepatocellular cancer on immunotherapy: a proof-of-concept study.
Lui TKL; Cheung KS; Leung WK
Hepatol Int; 2022 Aug; 16(4):879-891. PubMed ID: 35779202
[TBL] [Abstract][Full Text] [Related]
30. The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm.
Le Y; Xu W; Guo W
Technol Cancer Res Treat; 2023; 22():15330338231165131. PubMed ID: 37078130
[TBL] [Abstract][Full Text] [Related]
31. A Machine Learning Algorithm for Predicting the Risk of Developing to M1b Stage of Patients With Germ Cell Testicular Cancer.
Ding L; Wang K; Zhang C; Zhang Y; Wang K; Li W; Wang J
Front Public Health; 2022; 10():916513. PubMed ID: 35844840
[TBL] [Abstract][Full Text] [Related]
32. Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel.
Gandara D; Reck M; Moro-Sibilot D; Mazieres J; Gadgeel S; Morris S; Cardona A; Mendus D; Ballinger M; Rittmeyer A; Peters S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737340
[TBL] [Abstract][Full Text] [Related]
33. Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer.
Ramagopalan S; Gupta A; Arora P; Thorlund K; Ray J; Subbiah V
JAMA Netw Open; 2021 Nov; 4(11):e2134299. PubMed ID: 34767024
[TBL] [Abstract][Full Text] [Related]
34. Explainable Machine Learning Techniques To Predict Amiodarone-Induced Thyroid Dysfunction Risk: Multicenter, Retrospective Study With External Validation.
Lu YT; Chao HJ; Chiang YC; Chen HY
J Med Internet Res; 2023 Feb; 25():e43734. PubMed ID: 36749620
[TBL] [Abstract][Full Text] [Related]
35. Combinatorial Use of Machine Learning and Logistic Regression for Predicting Carotid Plaque Risk Among 5.4 Million Adults With Fatty Liver Disease Receiving Health Check-Ups: Population-Based Cross-Sectional Study.
Deng Y; Ma Y; Fu J; Wang X; Yu C; Lv J; Man S; Wang B; Li L
JMIR Public Health Surveill; 2023 Sep; 9():e47095. PubMed ID: 37676713
[TBL] [Abstract][Full Text] [Related]
36. A Web-Based Calculator to Predict Early Death Among Patients With Bone Metastasis Using Machine Learning Techniques: Development and Validation Study.
Lei M; Wu B; Zhang Z; Qin Y; Cao X; Cao Y; Liu B; Su X; Liu Y
J Med Internet Res; 2023 Oct; 25():e47590. PubMed ID: 37870889
[TBL] [Abstract][Full Text] [Related]
37. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
38. Impact of Intraoperative Data on Risk Prediction for Mortality After Intra-Abdominal Surgery.
Yan X; Goldsmith J; Mohan S; Turnbull ZA; Freundlich RE; Billings FT; Kiran RP; Li G; Kim M
Anesth Analg; 2022 Jan; 134(1):102-113. PubMed ID: 34908548
[TBL] [Abstract][Full Text] [Related]
39. Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies.
Sotelo M; Alonso-Gordoa T; Gajate P; Gallardo E; Morales-Barrera R; Pérez-Gracia JL; Puente J; Sánchez P; Castellano D; Durán I
Clin Transl Oncol; 2021 Apr; 23(4):882-891. PubMed ID: 32897497
[TBL] [Abstract][Full Text] [Related]
40. Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques.
Cui Y; Wang Q; Shi X; Ye Q; Lei M; Wang B
Front Oncol; 2022; 12():1095059. PubMed ID: 36568149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
